PRINCETON, NJ--(MARKET WIRE)--Aug 7, 2007 -- Barrier Therapeutics, Inc. (NasdaqGM:BTRX - News), a pharmaceutical company that develops and markets dermatology products, today announced its financial results for the second quarter ended June 30, 2007. Total revenues increased to $4.1 million for the second quarter of 2007 from $1.1 million in the second quarter of 2006, and represent 51% sequential growth over the first quarter of 2007. Revenue growth is due primarily to increased sales of Vusion® Ointment and Xolegel(TM) Gel. Net product revenues increased to $3.9 million from $1.1 million in the second quarter of 2006, and represent a 47% increase over the $2.6 million reported in the first quarter of 2007.
